We estimate that the CEO & President of AVALONBAY COMMUNITIES INC ($AVB), Benjamin W. Schall, received a compensation of $9,663,500 in 2025. This is an increase of 5.93% from an estimated $9,090,073 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 06, 2026. Note that parsing errors may occur.
You can track $AVB on Quiver Quantitative's $AVB stock dashboard.
$AVB Stock Insider Trading Activity
$AVB Stock insiders have traded $AVB stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AVB stock by insiders over the last 6 months:
- SEAN THOMAS WILLSON (Senior Vice President) sold 150 shares for an estimated $27,039
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AVB Stock Congressional Stock Trading
Members of Congress have traded $AVB stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $AVB stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$AVB Stock Hedge Fund Activity
We have seen 288 institutional investors add shares of $AVB Stock stock to their portfolio, and 396 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,753,567 shares (+3691.4%) to their portfolio in Q4 2025, for an estimated $317,939,232
- JPMORGAN CHASE & CO added 944,129 shares (+22.4%) to their portfolio in Q4 2025, for an estimated $171,180,028
- HOLOCENE ADVISORS, LP added 867,189 shares (+3570.6%) to their portfolio in Q4 2025, for an estimated $157,230,037
- NORGES BANK added 840,766 shares (+12.3%) to their portfolio in Q4 2025, for an estimated $152,439,283
- CLEARBRIDGE INVESTMENTS, LLC removed 661,806 shares (-29.2%) from their portfolio in Q4 2025, for an estimated $119,992,045
- CORIENT PRIVATE WEALTH LLC added 622,370 shares (+1181.0%) to their portfolio in Q4 2025, for an estimated $112,841,904
- MARSHALL WACE, LLP added 420,080 shares (+inf%) to their portfolio in Q4 2025, for an estimated $76,164,704
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AVB Stock Analyst Ratings
Wall Street analysts have issued reports on $AVB in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/20/2026
- Barclays issued a "Overweight" rating on 11/25/2025
- Morgan Stanley issued a "Overweight" rating on 11/13/2025
- Wells Fargo issued a "Overweight" rating on 11/10/2025
To track analyst ratings and price targets for $AVB Stock, check out Quiver Quantitative's $AVB forecast page.
$AVB Stock Price Targets
Multiple analysts have issued price targets for $AVB recently. We have seen 13 analysts offer price targets for $AVB in the last 6 months, with a median target of $191.0.
Here are some recent targets:
- Steve Sakwa from Evercore ISI Group set a target price of $191.0 on 04/06/2026
- Adam Kramer from Morgan Stanley set a target price of $203.0 on 03/26/2026
- Richard Hightower from Barclays set a target price of $202.0 on 03/06/2026
- Nicholas Yulico from Scotiabank set a target price of $190.0 on 03/04/2026
- Michael Lewis from Truist Securities set a target price of $201.0 on 03/04/2026
- Nick Joseph from Citigroup set a target price of $198.0 on 02/13/2026
- Richard Anderson from Cantor Fitzgerald set a target price of $186.0 on 02/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.